⏳ Fetching live dividend data...
Home › Calculator › MRNS Dividend Calculator 2026
Marinus Pharmaceuticals, Inc. · NASDAQ
Price: $0.55 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in MRNS → $45896.01M in 10 years · $2,999,739,063.02/month
Marinus Pharmaceuticals, Inc. is a specialized biopharmaceutical firm dedicated to the development and commercialization of therapeutic solutions for individuals suffering from rare genetic epilepsies and other seizure-related conditions. The company's primary commercialized product is ZTALMY, an oral suspension specifically designed to manage seizures associated with cyclin-dependent kinase-like 5 deficiency disorder (CDD). This medication is prescribed for both adult and pediatric patient populations, suitable for use in acute and chronic care settings, and can be administered either in-patient or by the patient themselves. ZTALMY exerts its effect by targeting synaptic and extrasynaptic GABAA receptors, a mechanism that also suggests potential anticonvulsant, antidepressant, and anxiolytic benefits. Beyond ZTALMY, Marinus is actively progressing ganaxolone through development, an investigational therapy aimed at various genetic epileptic conditions such as PCDH19-related epilepsy, tuberous sclerosis complex, and Lennox-Gastaut Syndrome, with additional exploration for depressive disorders. The company maintains strategic alliances, including licensing agreements with Purdue Neuroscience Company and CyDex Pharmaceuticals, Inc., as well as a collaborative partnership with Orion Corporation. Marinus Pharmaceuticals was established in 2003 and operates from its corporate headquarters in Radnor, Pennsylvania.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open MRNS position with:
Real after-tax yield depends on where you live and how you hold MRNS.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 363.64% | 360.84% | $36,364 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 309.09% | 306.29% | $30,909 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 290.91% | 288.11% | $29,091 / yr |
| 🇬🇧 UK ISA | 0% | 363.64% | 360.84% | $36,364 / yr |
| 🇬🇧 UK Taxable | 8.75% | 331.82% | 329.02% | $33,182 / yr |
| 🇨🇦 TFSA | 0% | 363.64% | 360.84% | $36,364 / yr |
| 🇨🇦 CA Taxable | 25% | 272.73% | 269.93% | $27,273 / yr |
| 🇦🇺 Super (pension) | 15% | 309.09% | 306.29% | $30,909 / yr |
| 🇦🇺 AU Taxable | 30% | 254.55% | 251.75% | $25,455 / yr |
| 🇩🇪 DE Taxable | 26.375% | 267.73% | 264.93% | $26,773 / yr |
| 🇫🇷 FR Taxable | 30% | 254.55% | 251.75% | $25,455 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
MRNS pays quarterly — 4 times per year. Next ex-div: TBD.
How MRNS compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for MRNS sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| D-Return | 2025-02-07 | 8,600 | $0.55 | $4.7K | ||
| D-Return | 2025-02-11 | 10,450 | $1.40 | $14.6K | ||
| D-Return | 2025-02-11 | 12,375 | $10.40 | $128.7K | ||
| D-Return | 2025-02-11 | 16,500 | $12.60 | $207.9K | ||
| D-Return | 2025-02-11 | 20,900 | $9.74 | $203.6K | ||
| D-Return | 2025-02-11 | 16,200 | $5.94 | $96.2K | ||
| D-Return | 2025-02-11 | 25,000 | $7.12 | $178.0K | ||
| D-Return | 2025-02-11 | 2,300 | $0.55 | $1.3K | ||
| D-Return | 2025-02-07 | 12,707 | $0.55 | $7.0K | ||
| D-Return | 2025-02-11 | 16,200 | $5.94 | $96.2K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the MRNS dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Marinus Pharmaceuticals, Inc. (MRNS) is currently trading at $0.55, 88% below its 52-week high. The current dividend yield is 363.64% based on an annual payout of $2.00 per share.
Marinus Pharmaceuticals, Inc. (MRNS) is a healthcare stock currently trading at $0.55 with a dividend yield of 363.64%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →